Internal Medicine · New York, NY
NPI
1598015620
Since 2012
Specialty
Internal Medicine
Code 207R00000X
Group practices
4
Medicare group memberships
Hospitals
0
Hospital affiliations
435 Fort Washington Ave Apt 1c
New York, NY, 10033
Phone (212) 932-0408
Groups this clinician bills Medicare through
Medicare paid, 2023
$5,969
113 services
Medicare patients, 2023
23
Average age 72
Drug cost, 2024
$1.2M
8,058 prescriptions
Company payments, 2025
$1,378
From 16 companies
Procedures and visits billed to Original Medicare, 2023
In 2023, the most common Medicare service billed by Jacobo Pena was code 99213 (office e&m - established), 22 times for 12 patients. In total Jacobo Pena billed 113 services in 18 codes, and Medicare paid $5,969.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-10-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 22 | 12 | $58.84 | $1,294 |
| 96127 Behavioral Health Services | Office | 15 | 11 | $3.96 | $59.46 |
| 36415 Venipuncture Blood Collection | Office | 13 | 13 | $8.40 | $109 |
| 93000 Electrocardiogram | Office | 12 | 12 | $11.00 | $132 |
By year: 2022 $5,729 for 123 services; 2023 $5,969 for 113 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 13 | 13 | $8.40 | $109 |
Medicare prescription drug claims, 2024
In 2024, the drug Jacobo Pena prescribed most often to Medicare patients was Atorvastatin Calcium, with 426 prescriptions and refills. In total Jacobo Pena wrote 8,058 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 426 | 1,182 | 160 | $6,022 |
| Omeprazole Generic | 299 | 775 | 117 | $4,269 |
| Amlodipine Besylate Generic | 276 | 759 | 106 | $1,558 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 235 | 304 | 55 | $8,848 |
| Naproxen Generic | 189 | 211 | 53 | $1,417 |
| Metformin Hcl Generic | 179 | 479 | 65 | $932 |
| Meclizine Hcl Generic | 159 | 284 | 56 | $1,444 |
| Ammonium Lactate Generic | 154 | 162 | 38 | $2,417 |
| Losartan Potassium Generic | 151 | 429 | 69 | $1,465 |
| Gabapentin Generic | 150 | 376 | 52 | $1,620 |
| Diclofenac Sodium Generic | 150 | 170 | 46 | $2,171 |
| Doxepin Hcl Generic | 144 | 172 | 52 | $78K |
| Fluticasone Propionate Generic | 142 | 182 | 32 | $1,089 |
| Montelukast Sodium Generic | 133 | 301 | 52 | $1,300 |
| Diclofenac Sodium Er Diclofenac Sodium | 119 | 139 | Under 11 | $8,465 |
Brand drugs: 1,429 claims; generic drugs: 6,285 claims; opioid claims: 25.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jacobo Pena $1,378 ($1,378 in general payments such as food, travel and fees) from 16 companies. The largest payer was Abbvie Inc. with $253.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 21 | $253 |
| Scilex Pharmaceuticals Inc. | 22 | $176 |
| Exact Sciences Corporation EXAS | 10 | $160 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 10 | $156 |
| GlaxoSmithKline, LLC. GSK | 8 | $142 |
| Amgen Inc. AMGN | 6 | $117 |
| Intra-Sana Laboratories | 3 | $73.84 |
| Astellas Pharma US Inc 4503.T | 2 | $64.14 |
| Lilly USA, LLC LLY | 2 | $52.89 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $44.36 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.